In this work, we introduced OPTN, wild-type or ALS-associated mutants, into Optn−/−MEF cells, and systematically assessed their potential effects on the activity of NF-κB pathway. The gene discussed is NFKB1; the disease is amyotrophic lateral sclerosis.